Japan headquartered Nippon Express Holdings has signed a strategic partnership agreement with Iceland-based Controlant, Inc., a leading provider of real-time monitoring devices for pharmaceuticals.

Through this strategic partnership agreement with Controlant, the NX Group will be able to provide transportation services with end-to-end monitoring of cargo status, especially for pharmaceutical and healthcare products requiring strict temperature control.

Customers will also be able to optimise their supply chain processes by linking the NX Group's e-NX Visibility tracking system with Controlant's real-time data logger.

Nippon Express (NX) Group has positioned the healthcare industry as a priority industry in its NX Group Business Plan 2028 - Dynamic Growth 2.0 "Accelerating Sustainable Growth." The Group has acquired Good Distribution Practices (GDP) and CEIV Pharma certification at 34 business locations in 24 countries/regions worldwide, and is working to build quality management systems and infrastructure.

On the other hand, Controlant's advanced technology and high-quality services, including platforms compliant with FDA 21 CFR Part 11 and GxP -validated IoT loggers, have been adopted by global pharmaceutical companies and logistics service providers around the world.